Kimberley J. Evason, MD, PhD

Dr. Kimberley J. Evason is an associate professor of pathology at the University of Utah School of Medicine and an investigator in the Department of Oncological Sciences at the Huntsman Cancer Institute. She received her medical and doctorate degrees through the Medical Scientist Training Program at Washington University in St. Louis. She served a residency and completed fellowship training in anatomic and liver/gastrointestinal pathology at the University of California at San Francisco, followed by a postdoctoral fellowship mentored by Didier Stainier, Andrei Goga, and J. Michael Bishop. Dr. Evason’s research and clinical interests are centered on gastrointestinal and liver pathology, with a specific focus on hepatocellular carcinoma. She is currently investigating molecular pathways and identifying drugs that influence liver tumorigenesis.

Gillian L. Hale, MD, MPH

Dr. Gillian L. Hale is a medical director of anatomic pathology at ARUP Laboratories and an associate professor (clinical) at the University of Utah School of Medicine. Dr. Hale received her medical degree from George Washington University. She then completed an anatomic and clinical pathology residency and a gastrointestinal and liver pathology fellowship, both at the University of California at San Francisco. Dr. Hale is a member of the Binford-Dammin Society of Infectious Disease Pathologists. Her research interests include infections of the liver and gastrointestinal tract.

Elizabeth A. Montgomery, MD

Dr. Elizabeth Montgomery trained at Walter Reed Army Medical Center in pathology. She is currently a professor of Pathology and vice chair of Faculty Development and Mentoring at the University of Miami Miller School of Medicine.

Dr. Montgomery has published numerous articles and books on gastrointestinal and soft tissue pathology and has trained numerous fellows in these disciplines. She was formerly a professor of Pathology, Oncology, and Orthopedic Surgery at Johns Hopkins University in Baltimore, Maryland, and division director of Gastrointestinal Pathology. She is the editor in chief of Innovative Science Press.

She is a highly sought-after speaker worldwide.

Elizabeth A. Montgomery, MD

Dr. Elizabeth Montgomery trained at Walter Reed Army Medical Center in pathology. She is currently a professor of Pathology and vice chair of Faculty Development and Mentoring at the University of Miami Miller School of Medicine.

Dr. Montgomery has published numerous articles and books on gastrointestinal and soft tissue pathology and has trained numerous fellows in these disciplines. She was formerly a professor of Pathology, Oncology, and Orthopedic Surgery at Johns Hopkins University in Baltimore, Maryland, and division director of Gastrointestinal Pathology. She is the editor in chief of Innovative Science Press.

She is a highly sought-after speaker worldwide.

Elizabeth A. Montgomery, MD

Dr. Elizabeth Montgomery trained at Walter Reed Army Medical Center in pathology. She is currently a professor of Pathology and vice chair of Faculty Development and Mentoring at the University of Miami Miller School of Medicine.

Dr. Montgomery has published numerous articles and books on gastrointestinal and soft tissue pathology and has trained numerous fellows in these disciplines. She was formerly a professor of Pathology, Oncology, and Orthopedic Surgery at Johns Hopkins University in Baltimore, Maryland, and division director of Gastrointestinal Pathology. She is the editor in chief of Innovative Science Press.

She is a highly sought-after speaker worldwide.

Alexander Kikuchi, MD, PhD

Dr. Alexander Kikuchi is a medical director at ARUP Laboratories, and an associate professor (clinical) at the University of Utah School of Medicine. He received his medical and doctorate degrees from the University of Pittsburgh School of Medicine and did his residency in pathology at the University of California San Francisco. He completed fellowships in gastrointestinal and hepatobiliary pathology, and surgical pathology at the University of California San Francisco. Dr. Kikuchi is board certified in anatomic pathology by the American Board of Pathology. He is a member of the Hans Popper Hepatopathology Society, the Rodger C. Haggit Gastrointestinal Pathology Society, and the Pancreatobiliary Pathology Society. He has received awards from the Hans Popper Hepatopathology Society Best Trainee Abstract Award (1st place) at the 2022 USCAP Meeting, the Robert E. Lee, MD, Award for Excellence in Anatomic Pathology (University of Pittsburgh School of Medicine, 2019), Presidential Poster Award at the 2017 AASLD Conference, Summa Cum Laude (University of Southern California, 2010), and a Renaissance Scholar (University of Southern California, 2010). Dr. Kikuchi’s research interests include histopathologic and molecular classification of primary liver neoplasms, chronic liver injury, hepatic fibrosis, and hepatic carcinogenesis.

Kajsa Affolter, MD

Dr. Kajsa Affolter is the medical director of anatomic pathology at ARUP Laboratories and an associate professor (clinical) at the University of Utah School of Medicine. Dr. Affolter graduated from Kansas University School of Medicine with a medical degree. She completed both an anatomic and clinical pathology residency and a gastrointestinal pancreatic and hepatobiliary pathology fellowship at the University of Utah. Dr. Affolter is certified by the American Board of Pathology. She specializes in gastrointestinal, pancreatic, and hepatobiliary pathology, and her research interests include pancreatic neoplasia, inflammatory bowel disease, and gastrointestinal polyposis syndromes.

Valarie McMurtry, MD, PhD

Dr. Valarie McMurtry is a medical director of molecular oncology at ARUP Laboratories, and an assistant professor (clinical) at the University of Utah School of Medicine. She received her medical and doctorate degrees from Louisiana State University, Health Science Center. Dr. McMurtry completer her residency in anatomic and clinical pathology and fellowships in cytology and molecular genetics pathology at the University of Utah School of Medicine. She is board certified in anatomic and clinical pathology by the American Board of Pathology. Her research interests include solid tumor molecular genetics.

Angelica Putnam, MD

Dr. Putnam is a professor (clinical) in the Division of Pediatric Pathology, located at Primary Children's Hospital. She serves as Director of Undergraduate Medical Education for the Department of Pathology and Director of Anatomic Pathology Quality Assurance/Improvement Program for the Division of Pediatric Pathology.

Her interests include pediatric vascular lesions, soft tissue tumors, and sarcomas. She devotes most of her time to surgical pathology, teaching, developing undergraduate medical education curriculum, and authoring the medical textbooks Diagnostic Pathology: Non-Neoplastic Pediatric and Diagnostic Pathology: Pediatric Neoplasms with Elsevier.

Dr. Putnam received her medical degree, completed residency training in anatomic and clinical pathology and fellowship training in pediatric pathology, all at the University of Utah School of Medicine. An additional fellowship in general surgical pathology was completed at the University of Colorado at Denver and Health Sciences Center. She is board certified in anatomic, clinical, and pediatric pathology.

Dr. Putnam is a member of several professional societies, including the College of American Pathologists, Society of Pediatric Pathology, Association of Pathology Chairs, and the International Association of Medical Science Educators. Her primary research interest is in pathology education.

Scott R. Florell, MD

Dr. Scott R. Florell is a consulting medical director of dermatology at ARUP Laboratories and a professor of dermatology at the University of Utah School of Medicine. Dr. Florell received his medical degree from the University of Nebraska College of Medicine. He completed residencies in dermatology and anatomic and clinical pathology at the University of Utah School of Medicine. Dr. Florell is certified in dermatology by the American Board of Dermatology and in anatomic and clinical pathology by the American Board of Pathology. His research interests include melanoma and cutaneous oncology.

Beatrice Knudsen, MD, PhD

Dr. Beatrice Knudsen is a medical director of computational pathology at ARUP Laboratories and a professor (clinical) at the University of Utah School of Medicine. Dr. Knudsen received both her doctorate and medical degrees from Weill Cornell Medical School. She completed a residency at the New York Hospital before completing a laboratory research fellowship at Rockefeller University. Dr. Knudsen is board certified and the recipient of the Creativity Award from the Prostate Cancer Foundation. She specializes in genitourinary pathology and her research interests include mechanisms of cancer metastases and biomarker development.

Kimberley J. Evason, MD, PhD

Dr. Kimberley J. Evason is an associate professor of pathology at the University of Utah School of Medicine and an investigator in the Department of Oncological Sciences at the Huntsman Cancer Institute. She received her medical and doctorate degrees through the Medical Scientist Training Program at Washington University in St. Louis. She served a residency and completed fellowship training in anatomic and liver/gastrointestinal pathology at the University of California at San Francisco, followed by a postdoctoral fellowship mentored by Didier Stainier, Andrei Goga, and J. Michael Bishop. Dr. Evason’s research and clinical interests are centered on gastrointestinal and liver pathology, with a specific focus on hepatocellular carcinoma. She is currently investigating molecular pathways and identifying drugs that influence liver tumorigenesis.

Juan F. Gallegos-Orozco, MD

Dr. Juan F. Gallegos-Orozco graduated from medical school in Mexico and completed postgraduate medical education in internal medicine and gastroenterology in both Mexico and the United States, where he completed fellowship training in Transplant Hepatology at the prestigious Mayo School of Graduate Medical Education, Mayo Clinic in Phoenix, Arizona, in June 2012. His main clinical and research interests include the management of chronic viral hepatitis, nonalcoholic fatty liver disease and liver transplantation. He has published many research articles on these and other topics and has authored several book chapters pertaining to liver diseases. Dr. Gallegos-Orozco joined the Division of Gastroenterology, Hepatology and Nutrition at the University of Utah School of Medicine in July 2012 and is currently an associate professor of medicine and serves as the medical director for Hepatology and Liver Transplant.

Mariana Moreno-Prats, MD

Dr. Mariana Moreno-Prats is a medical director at ARUP Laboratories, and an assistant professor (clinical) at the University of Utah School of Medicine. Dr. Moreno-Prats completed her medical degree at the University of Puerto Rico School of Medicine. She then completed her residency in anatomic and clinical pathology at the University of Texas Medical Branch and a fellowship in gastrointestinal pancreatic and hepatobiliary pathology at the University of Utah School of Medicine. Dr. Moreno-Prats is certified by the American Board of Pathology. She specializes in gastrointestinal, hepatic, and pancreatic pathology. Her research interests include chronic liver disease and celiac disease.

Evan Raps, MD

Dr. Evan Raps is a medical director at ARUP Laboratories, and an assistant professor (clinical) at the University of Utah School of Medicine. Dr. Raps completed his medical degree at the University of Nevada Medical School. He then completed his residency in anatomic and clinical pathology at the University of Utah School of Medicine as well as a residency in anatomic pathology at the University of Utah School of Medicine/ARUP Laboratories and a cytopathology fellowship at the University of Utah School of Medicine. Dr. Raps is certified by the American Board of Pathology. He specializes in cytopathology as well as head and neck pathology. His research interests include digital pathology.

Andrew M. Bellizzi, MD

Dr. Andrew M. Bellizzi is a clinical professor in the Department of Pathology at the University of Iowa. Dr. Bellizzi completed undergraduate work in Anthropology and Science Preprofessional Studies at the University of Notre Dame and received his medical degree from Northwestern University. Following combined training in anatomic and clinical pathology at the University of Virginia, he completed a fellowship in gastrointestinal and liver pathology at The Ohio State University. Dr. Bellizzi served as a junior faculty member at Brigham and Women’s Hospital for two years before moving to Iowa.

Dr. Bellizzi is director of Immunohistochemistry and GI Pathology and codirector of the GI Pathology Fellowship at the University of Iowa. He is an active member of the United States and Canadian Academy of Pathology (USCAP), the American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), and the North American Neuroendocrine Tumor Society (NANETS), including serving as the immediate past chair of the USCAP Stowell-Orbison Award and the CAP Immunohistochemistry committees. He is secretary-treasurer of the International Society for Immunohistochemistry and Molecular Morphology. Dr. Bellizzi serves as an associate editor (reviews) for Applied Immunohistochemistry and Molecular Morphology, a section editor (immunohistochemistry) for Archives of Pathology and Laboratory Medicine, and an assistant editor (GI pathology) for the American Journal of Clinical Pathology. He is on the Neuroendocrine Tumor Expert Panel for the ninth edition of the AJCC Cancer Staging Manual.

Dr. Bellizzi’s research interests include the diagnosis, classification, and etiopathogenesis of human disease, with an emphasis on gastrointestinal, pancreatic, neuroendocrine, and hereditary tumors. His research program focuses on applications of diagnostic immunohistochemistry.

Andrew M. Bellizzi, MD

Dr. Andrew M. Bellizzi is a clinical professor in the Department of Pathology at the University of Iowa. Dr. Bellizzi completed undergraduate work in Anthropology and Science Preprofessional Studies at the University of Notre Dame and received his medical degree from Northwestern University. Following combined training in anatomic and clinical pathology at the University of Virginia, he completed a fellowship in gastrointestinal and liver pathology at The Ohio State University. Dr. Bellizzi served as a junior faculty member at Brigham and Women’s Hospital for two years before moving to Iowa.

Dr. Bellizzi is director of Immunohistochemistry and GI Pathology and codirector of the GI Pathology Fellowship at the University of Iowa. He is an active member of the United States and Canadian Academy of Pathology (USCAP), the American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), and the North American Neuroendocrine Tumor Society (NANETS), including serving as the immediate past chair of the USCAP Stowell-Orbison Award and the CAP Immunohistochemistry committees. He is secretary-treasurer of the International Society for Immunohistochemistry and Molecular Morphology. Dr. Bellizzi serves as an associate editor (reviews) for Applied Immunohistochemistry and Molecular Morphology, a section editor (immunohistochemistry) for Archives of Pathology and Laboratory Medicine, and an assistant editor (GI pathology) for the American Journal of Clinical Pathology. He is on the Neuroendocrine Tumor Expert Panel for the ninth edition of the AJCC Cancer Staging Manual.

Dr. Bellizzi’s research interests include the diagnosis, classification, and etiopathogenesis of human disease, with an emphasis on gastrointestinal, pancreatic, neuroendocrine, and hereditary tumors. His research program focuses on applications of diagnostic immunohistochemistry.

Cameron Beech, MD

Dr. Cameron Beech is a medical director of Solid Tumor Molecular Oncology at ARUP Laboratories, and an assistant professor (clinical) for the University of Utah School of Medicine. He received his medical degree from the University of Toledo College of Medicine and did his residency in anatomic and clinical pathology at Yale New Haven Hospital. He completed fellowships in oncologic surgical pathology and molecular genetic pathology at Memorial Sloan Kettering Cancer Center and gastrointestinal, pancreatic, and hepatobiliary pathology at Yale New Haven Hospital. Dr. Beech is board certified in anatomic and clinical pathology and molecular genetic pathology by the American Board of Pathology. His research interests include application of next generation sequencing to solid tumors and genomic alteration in gastrointestinal malignancies.

Katherine Boylan, MD

Dr. Katherine Boylan is a medical director of anatomic pathology at ARUP Laboratories and an assistant professor (clinical) at the University of Utah School of Medicine. Dr. Boylan received her medical degree from Charles E. Schmidt College of Medicine at Florida Atlantic University. She completed her residency in anatomic and clinical pathology at the University of Utah School of Medicine, and a fellowship in gastrointestinal and hepatobiliary pathology at the University of Chicago School of Medicine. Dr. Boylan is certified in anatomic and clinical pathology by the American Board of Pathology. She received an honorable mention award from the Rodger C. Haggitt Gastrointestinal Pathology Society for her Gastrointestinal Pathology – 2020 Abstract. Her research interests include sessile serrated polyps and the serrated colon cancer pathway, as well as pathology resident education.

Andrew M. Bellizzi, MD

Dr. Andrew M. Bellizzi is a clinical professor in the Department of Pathology at the University of Iowa. Dr. Bellizzi completed undergraduate work in Anthropology and Science Preprofessional Studies at the University of Notre Dame and received his medical degree from Northwestern University. Following combined training in anatomic and clinical pathology at the University of Virginia, he completed a fellowship in gastrointestinal and liver pathology at The Ohio State University. Dr. Bellizzi served as a junior faculty member at Brigham and Women’s Hospital for two years before moving to Iowa.

Dr. Bellizzi is director of Immunohistochemistry and GI Pathology and codirector of the GI Pathology Fellowship at the University of Iowa. He is an active member of the United States and Canadian Academy of Pathology (USCAP), the American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), and the North American Neuroendocrine Tumor Society (NANETS), including serving as the immediate past chair of the USCAP Stowell-Orbison Award and the CAP Immunohistochemistry committees. He is secretary-treasurer of the International Society for Immunohistochemistry and Molecular Morphology. Dr. Bellizzi serves as an associate editor (reviews) for Applied Immunohistochemistry and Molecular Morphology, a section editor (immunohistochemistry) for Archives of Pathology and Laboratory Medicine, and an assistant editor (GI pathology) for the American Journal of Clinical Pathology. He is on the Neuroendocrine Tumor Expert Panel for the ninth edition of the AJCC Cancer Staging Manual.

Dr. Bellizzi’s research interests include the diagnosis, classification, and etiopathogenesis of human disease, with an emphasis on gastrointestinal, pancreatic, neuroendocrine, and hereditary tumors. His research program focuses on applications of diagnostic immunohistochemistry.

Jeffrey R. Jacobsen, MD

Dr. Jeffrey Jacobsen is a medical director of hematopathology at ARUP Laboratories, and an associate professor (clinical) at the University of Utah School of Medicine. Dr. Jacobsen graduated from the University of Illinois College of Medicine with his medical degree. He completed a residency in anatomic and clinical pathology as well as a fellowship in hematopathology at the University of Utah School of Medicine. Dr. Jacobsen is certified by the American Board of Pathology in hematopathology and anatomic and clinical pathology. He specializes in hematologic flow cytometry and pediatric hematopathology. His research interests include clinical flow cytometry and the role of immune composition in leukemia therapy.